Literature DB >> 9931155

Antihypertensive mechanisms underlying a novel salt-sensitive hypertensive model induced by sensory denervation.

D H Wang1, J Li.   

Abstract

A novel model of hypertension recently developed in our laboratory shows that neonatal degeneration of capsaicin-sensitive sensory nerves renders a rat responsive to a salt load with a significant rise in blood pressure. To determine the role of the renin-angiotensin system and the sympathetic nervous system in the development of hypertension in this model, newborn Wistar rats were given capsaicin 50 mg/kg SC on the first and second days of life. Control rats were treated with vehicle. After they were weaned, male rats were divided into 6 groups and subjected to the following treatments for 2 weeks: control+high sodium diet (4%) (CON-HS), capsaicin+normal sodium diet (0.5%) (CAP-NS), capsaicin+high sodium diet (CAP-HS), capsaicin+high sodium diet+losartan (10 mg/kg per day) (CAP-HS-LO), capsaicin+high sodium diet+prazosin (3 mg/kg per day) (CAP-HS-PR), and capsaicin+high sodium diet+hydralazine (10 mg/kg per day) (CAP-HS-HY). Levels of calcitonin gene-related peptide in dorsal root ganglia were decreased by capsaicin treatment (P<0.05). Both tail-cuff systolic blood pressure and mean arterial pressure were higher in CAP-HS and CAP-HS-PR than in CON-HS, CAP-NS, CAP-HS-LO, and CAP-HS-HY (P<0.05). The 24-hour urinary volume and sodium excretion were increased when a high sodium diet was given (P<0.05), but they were lower in CAP-HS, CAP-HS-LO, CAP-HS-PR, and CAP-HS-HY than in CON-HS (P<0.05). Urinary potassium excretion was not different among all 6 groups. We conclude that blockade of the angiotensin type 1 receptor with losartan but not antagonism of the alpha1-adrenoreceptor with prazosin prevents the development of salt-sensitive hypertension induced by sensory denervation. Sensory denervation impairs urinary sodium and water excretion in response to a high sodium intake, regardless of blood pressure, suggesting that sensory innervation plays a direct role in regulating the natriuretic response to sodium loading.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931155     DOI: 10.1161/01.hyp.33.1.499

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Intrathecal injection of TRPV1 shRNA leads to increases in blood pressure in rats.

Authors:  S-Q Yu; D H Wang
Journal:  Acta Physiol (Oxf)       Date:  2011-04-22       Impact factor: 6.311

2.  Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia.

Authors:  L Tual; O-E Morel; F Favret; M Fouillit; C Guernier; A Buvry; L Germain; G Dhonneur; J-F Bernaudin; J-P Richalet
Journal:  Pflugers Arch       Date:  2006-04-26       Impact factor: 3.657

3.  Enhanced salt sensitivity following shRNA silencing of neuronal TRPV1 in rat spinal cord.

Authors:  Shuang-quan Yu; Donna H Wang
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

4.  Localization of NADPH oxidase in sympathetic and sensory ganglion neurons and perivascular nerve fibers.

Authors:  Xian Cao; Stacie L Demel; Mark T Quinn; James J Galligan; David Kreulen
Journal:  Auton Neurosci       Date:  2009-08-27       Impact factor: 3.145

Review 5.  Transient receptor potential vanilloid channels in hypertension, inflammation, and end organ damage: an imminent target of therapy for cardiovascular disease?

Authors:  Donna H Wang
Journal:  Curr Opin Cardiol       Date:  2008-07       Impact factor: 2.161

6.  Ablation of TRPV1-positive nerves exacerbates salt-induced hypertension and tissue injury in rats after renal ischemia-reperfusion via infiltration of macrophages.

Authors:  Shuang-Quan Yu; Shuangtao Ma; Donna H Wang
Journal:  Clin Exp Hypertens       Date:  2020-12-16       Impact factor: 1.749

Review 7.  Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension.

Authors:  I Márquez-Rodas; F Longo; R P Rothlin; G Balfagón
Journal:  J Physiol Biochem       Date:  2006-03       Impact factor: 5.080

Review 8.  Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases.

Authors:  Abimael González-Hernández; Bruno A Marichal-Cancino; Jair Lozano-Cuenca; Jorge S López-Canales; Enriqueta Muñoz-Islas; Martha B Ramírez-Rosas; Carlos M Villalón
Journal:  Biomed Res Int       Date:  2016-12-27       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.